{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:05:45Z","timestamp":1791515145202,"version":"4.3.4"},"reference-count":183,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["ersjournals.com"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>Inflammation is a key feature in the pathogenesis of sepsis and acute respiratory distress syndrome (ARDS). Sepsis and ARDS continue to be associated with high mortality. A key contributory factor is the rudimentary understanding of the early events in pulmonary and systemic inflammation in humans, which are difficult to study in clinical practice, as they precede the patient's presentation to medical services. Lipopolysaccharide (LPS), a constituent of the outer membrane of Gram-negative bacteria, is a trigger of inflammation and the dysregulated host response in sepsis. Human LPS models deliver a small quantity of LPS to healthy volunteers, triggering an inflammatory response and providing a window to study early inflammation in humans. This allows biological\/mechanistic insights to be made and new therapeutic strategies to be tested in a controlled, reproducible environment from a defined point in time. We review the use of human LPS models, focussing on the underlying mechanistic insights that have been gained by studying the response to intravenous and pulmonary LPS challenge. We discuss variables that may influence the response to LPS before considering factors that should be considered when designing future human LPS studies.<\/jats:p>","DOI":"10.1183\/13993003.01298-2019","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T22:15:31Z","timestamp":1587075331000},"page":"1901298","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":95,"title":["Human lipopolysaccharide models provide mechanistic and therapeutic insights into systemic and pulmonary inflammation"],"prefix":"10.1183","volume":"56","author":[{"given":"Daniel","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wiscombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3283-1947","authenticated-orcid":false,"given":"Daniel F.","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-7294","authenticated-orcid":false,"given":"A. John","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9336-1723","authenticated-orcid":false,"given":"Anthony J.","family":"Rostron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"2020073006074856000_56.1.1901298.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701380"},{"key":"2020073006074856000_56.1.1901298.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0291"},{"key":"2020073006074856000_56.1.1901298.3","doi-asserted-by":"publisher","DOI":"10.4161\/viru.26083"},{"key":"2020073006074856000_56.1.1901298.4","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-31-2-73"},{"key":"2020073006074856000_56.1.1901298.5","doi-asserted-by":"publisher","DOI":"10.1179\/096805103225002539"},{"key":"2020073006074856000_56.1.1901298.6","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.7.563"},{"key":"2020073006074856000_56.1.1901298.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(97)90167-0"},{"key":"2020073006074856000_56.1.1901298.8","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2012.155"},{"key":"2020073006074856000_56.1.1901298.9","doi-asserted-by":"publisher","DOI":"10.1086\/314717"},{"key":"2020073006074856000_56.1.1901298.10","doi-asserted-by":"publisher","DOI":"10.2174\/092986708784872393"},{"key":"2020073006074856000_56.1.1901298.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.06.004"},{"key":"2020073006074856000_56.1.1901298.12","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.006213"},{"key":"2020073006074856000_56.1.1901298.13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s004050000285","article-title":"Lipopolysaccharide-induced nasal cytokine response: A dose-response evaluation","volume":"257","author":"Danuser","year":"2000","journal-title":"Eur Arch Oto-Rhino-Laryngology"},{"key":"2020073006074856000_56.1.1901298.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03921.x"},{"key":"2020073006074856000_56.1.1901298.15","doi-asserted-by":"crossref","first-page":"e0135363","DOI":"10.1371\/journal.pone.0135363","article-title":"Nasal lipopolysaccharide challenge and cytokine measurement reflects innate mucosal immune responsiveness","volume":"10","author":"Dhariwal","year":"2015","journal-title":"PLoS One"},{"key":"2020073006074856000_56.1.1901298.16","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0512250"},{"key":"2020073006074856000_56.1.1901298.17","doi-asserted-by":"publisher","DOI":"10.3109\/08830189009056632"},{"key":"2020073006074856000_56.1.1901298.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(11)80338-4"},{"key":"2020073006074856000_56.1.1901298.19","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.4.637-646.2003"},{"key":"2020073006074856000_56.1.1901298.20","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1863"},{"key":"2020073006074856000_56.1.1901298.21","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011247"},{"key":"2020073006074856000_56.1.1901298.22","doi-asserted-by":"publisher","DOI":"10.1038\/nri3446"},{"key":"2020073006074856000_56.1.1901298.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2013.04.010"},{"key":"2020073006074856000_56.1.1901298.24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-014-0028-1","article-title":"Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers","volume":"11","author":"Dillingh","year":"2014","journal-title":"J Inflamm"},{"key":"2020073006074856000_56.1.1901298.25","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.1.145"},{"key":"2020073006074856000_56.1.1901298.26","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819c3c67"},{"key":"2020073006074856000_56.1.1901298.27","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.4049\/jimmunol.155.10.5038","article-title":"Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration","volume":"155","author":"Suffredini","year":"1995","journal-title":"J Immunol"},{"key":"2020073006074856000_56.1.1901298.28","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.1.60-67.2005"},{"key":"2020073006074856000_56.1.1901298.29","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000209523.05249.27"},{"key":"2020073006074856000_56.1.1901298.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198908033210503"},{"key":"2020073006074856000_56.1.1901298.31","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000152229.69180.2"},{"key":"2020073006074856000_56.1.1901298.32","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3.860"},{"key":"2020073006074856000_56.1.1901298.33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/09680519000060040501","article-title":"Asystole following endotoxin administration","volume":"6","author":"Williams","year":"2000","journal-title":"J Endotoxin Res"},{"key":"2020073006074856000_56.1.1901298.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-004-2477-0"},{"key":"2020073006074856000_56.1.1901298.35","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200305000-00030"},{"key":"2020073006074856000_56.1.1901298.36","doi-asserted-by":"publisher","DOI":"10.1179\/096805105X58715"},{"key":"2020073006074856000_56.1.1901298.37","doi-asserted-by":"publisher","DOI":"10.1086\/346043"},{"key":"2020073006074856000_56.1.1901298.38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/CS20150591","article-title":"Potent irreversible P2Y12 inhibition does not reduce LPS-induced coagulation activation in a randomized, double-blind, placebo-controlled trial","volume":"130","author":"Schoergenhofer","year":"2016","journal-title":"Clin Sci"},{"key":"2020073006074856000_56.1.1901298.39","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000215514.96888.E3"},{"key":"2020073006074856000_56.1.1901298.40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01192.x"},{"key":"2020073006074856000_56.1.1901298.41","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1182\/blood.V89.8.2701","article-title":"Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia","volume":"89","author":"Pajkrt","year":"1997","journal-title":"Blood"},{"key":"2020073006074856000_56.1.1901298.42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.3.1845"},{"key":"2020073006074856000_56.1.1901298.43","first-page":"3727","article-title":"Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans","volume":"89","author":"van der Poll T","year":"1997","journal-title":"Blood"},{"key":"2020073006074856000_56.1.1901298.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.10.003"},{"key":"2020073006074856000_56.1.1901298.45","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000126265.08175.BE"},{"key":"2020073006074856000_56.1.1901298.46","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.10.2517"},{"key":"2020073006074856000_56.1.1901298.47","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.25.2485"},{"key":"2020073006074856000_56.1.1901298.48","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000118280.95422.48"},{"key":"2020073006074856000_56.1.1901298.49","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V95.5.1729.005k16_1729_1734","article-title":"Lepirudin blunts endotoxin-induced coagulation activation","volume":"95","author":"Pernerstorfer","year":"2000","journal-title":"Blood"},{"key":"2020073006074856000_56.1.1901298.50","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.6.1143"},{"key":"2020073006074856000_56.1.1901298.51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038255"},{"key":"2020073006074856000_56.1.1901298.52","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1182\/blood.V82.10.2985.bloodjournal82102985","article-title":"Hematologic and immunomodulatory effects of an interleukin 1 receptor antagonist coinfusion during low dose endotoxemia in healthy humans","volume":"15","author":"Granowitz E","year":"1993","journal-title":"Blood"},{"key":"2020073006074856000_56.1.1901298.53","doi-asserted-by":"publisher","DOI":"10.1177\/0885066615606673"},{"key":"2020073006074856000_56.1.1901298.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.09.034"},{"key":"2020073006074856000_56.1.1901298.55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/JLB.MR0318-104R","article-title":"Long-term reprogramming of the innate immune system","volume":"105","author":"Dominguez-Andres","year":"2019","journal-title":"J Leukoc Biol"},{"key":"2020073006074856000_56.1.1901298.56","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3MR0316-118RR"},{"key":"2020073006074856000_56.1.1901298.57","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/ars.2017.7310","article-title":"Epigenetics and trained immunity","volume":"29","author":"van der Heijden","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"2020073006074856000_56.1.1901298.58","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24738-0_6"},{"key":"2020073006074856000_56.1.1901298.59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707757104"},{"key":"2020073006074856000_56.1.1901298.60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018277"},{"key":"2020073006074856000_56.1.1901298.61","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/SHK.0000000000000248","article-title":"Integrated transcriptional and metabolic profiling in human endotoxemia","volume":"42","author":"Kamisoglu","year":"2014","journal-title":"Shock"},{"key":"2020073006074856000_56.1.1901298.62","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00192.2005"},{"key":"2020073006074856000_56.1.1901298.63","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/JLB.4A0219-050R","article-title":"Leukocyte transcriptional signatures dependent on LPS dosage in human endotoxemia","volume":"106","author":"Khan","year":"2019","journal-title":"J Leukoc Biol"},{"key":"2020073006074856000_56.1.1901298.64","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000063"},{"key":"2020073006074856000_56.1.1901298.65","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0783-2"},{"key":"2020073006074856000_56.1.1901298.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2009.07.009"},{"key":"2020073006074856000_56.1.1901298.67","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802189"},{"key":"2020073006074856000_56.1.1901298.68","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3182190d5d"},{"key":"2020073006074856000_56.1.1901298.69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/SHK.0000000000000384","article-title":"Hormone and cytokine responses to repeated endotoxin exposures no evidence of endotoxin tolerance after 5 weeks in humans","volume":"44","author":"Rittig","year":"2015","journal-title":"Shock"},{"key":"2020073006074856000_56.1.1901298.70","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04350.x"},{"key":"2020073006074856000_56.1.1901298.71","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198908000-00018"},{"key":"2020073006074856000_56.1.1901298.72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1159"},{"key":"2020073006074856000_56.1.1901298.73","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/SHK.0b013e3181598a6a","article-title":"Effects of prednisolone on the systemic release of mediators of cell-mediated cytotoxicity during human endotoxemia","volume":"29","author":"de Kruif","year":"2008","journal-title":"Shock"},{"key":"2020073006074856000_56.1.1901298.74","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.306528"},{"key":"2020073006074856000_56.1.1901298.75","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.158.3.1490","article-title":"Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia: effect of neutralization of endotoxin-induced TNF activity by infusion of a recombinant dimeric TNF receptor","volume":"158","author":"van der Poll","year":"1997","journal-title":"J Immunol"},{"key":"2020073006074856000_56.1.1901298.76","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118469"},{"key":"2020073006074856000_56.1.1901298.77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1322174111"},{"key":"2020073006074856000_56.1.1901298.78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2249.2006.03248.x","article-title":"Nicotine exposure alters in vivo human responses to endotoxin","volume":"147","author":"Wittebole","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2020073006074856000_56.1.1901298.79","doi-asserted-by":"publisher","DOI":"10.1186\/cc10576"},{"key":"2020073006074856000_56.1.1901298.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.07.002"},{"key":"2020073006074856000_56.1.1901298.81","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/stem.2891","article-title":"Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, single-blind, parallel group, placebo controlled trial","volume":"36","author":"Perlee","year":"2018","journal-title":"Stem Cells"},{"key":"2020073006074856000_56.1.1901298.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.06.002"},{"key":"2020073006074856000_56.1.1901298.83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vph.2014.01.007","article-title":"Effect of systemic high dose vitamin C therapy on forearm blood flow reactivity during endotoxemia in healthy human subjects","volume":"61","author":"Aschauer","year":"2014","journal-title":"Vascul Pharmacol"},{"key":"2020073006074856000_56.1.1901298.84","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/ajrccm.159.3.9805087","article-title":"Regulation of adhesion molecules during human endotoxemia no acute effects of aspirin","volume":"1","author":"Jilma","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2020073006074856000_56.1.1901298.85","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/01.CCM.0000275385.45557.25","article-title":"Effects of N-acetylcysteine against systemic and renal hemodynamic effects of endotoxin in healthy humans","volume":"35","author":"Schaller","year":"2007","journal-title":"Crit Care Med"},{"key":"2020073006074856000_56.1.1901298.86","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00490206"},{"key":"2020073006074856000_56.1.1901298.87","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vascn.2017.10.004","article-title":"Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia","volume":"89","author":"van Poelgeest","year":"2018","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2020073006074856000_56.1.1901298.88","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819598af"},{"key":"2020073006074856000_56.1.1901298.89","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000266534.14262.E8"},{"key":"2020073006074856000_56.1.1901298.90","doi-asserted-by":"publisher","DOI":"10.1086\/320723"},{"key":"2020073006074856000_56.1.1901298.91","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1994.01420260116016"},{"key":"2020073006074856000_56.1.1901298.92","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-63"},{"key":"2020073006074856000_56.1.1901298.93","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201300368"},{"key":"2020073006074856000_56.1.1901298.94","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114651"},{"key":"2020073006074856000_56.1.1901298.95","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rmed.2005.06.003","article-title":"Inhaled endotoxin in healthy human subjects: A dose-related study on systemic effects and peripheral CD4+ and CD8+ T cells","volume":"100","author":"Loh","year":"2006","journal-title":"Respir Med"},{"key":"2020073006074856000_56.1.1901298.96","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.114249"},{"key":"2020073006074856000_56.1.1901298.97","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00105308"},{"key":"2020073006074856000_56.1.1901298.98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-097X.2011.01058.x"},{"key":"2020073006074856000_56.1.1901298.99","doi-asserted-by":"publisher","DOI":"10.1179\/096805106X153934"},{"key":"2020073006074856000_56.1.1901298.100","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.1.9808144"},{"key":"2020073006074856000_56.1.1901298.101","doi-asserted-by":"publisher","DOI":"10.1378\/chest.102.4.1095"},{"key":"2020073006074856000_56.1.1901298.102","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2013.1089"},{"key":"2020073006074856000_56.1.1901298.103","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200810-1584OC"},{"key":"2020073006074856000_56.1.1901298.104","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pupt.2006.08.002","article-title":"Evaluation of oral corticosteroids and phosphodiesterase-4 inhibitor on the acute inflammation induced by inhaled lipopolysaccharide in human","volume":"20","author":"Michel","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"key":"2020073006074856000_56.1.1901298.105","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00078804"},{"key":"2020073006074856000_56.1.1901298.106","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.03.025"},{"key":"2020073006074856000_56.1.1901298.107","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01429.2005"},{"key":"2020073006074856000_56.1.1901298.108","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.7.2009111"},{"key":"2020073006074856000_56.1.1901298.109","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200904-0501OC"},{"key":"2020073006074856000_56.1.1901298.110","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000320"},{"key":"2020073006074856000_56.1.1901298.111","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200708-1261OC"},{"key":"2020073006074856000_56.1.1901298.112","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00057112"},{"key":"2020073006074856000_56.1.1901298.113","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2008.02.002"},{"key":"2020073006074856000_56.1.1901298.114","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pupt.2015.10.011","article-title":"Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers","volume":"35","author":"Holz","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"key":"2020073006074856000_56.1.1901298.115","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1160\/TH04-08-0492","article-title":"Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers","volume":"93","author":"Maris","year":"2005","journal-title":"Thromb Haemost"},{"key":"2020073006074856000_56.1.1901298.116","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000249827.29387.4E"},{"key":"2020073006074856000_56.1.1901298.117","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819584f9"},{"key":"2020073006074856000_56.1.1901298.118","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13504"},{"key":"2020073006074856000_56.1.1901298.119","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200411-1483OC"},{"key":"2020073006074856000_56.1.1901298.120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10753-010-9286-0","article-title":"Time course of endotoxin-induced airways\u2019 inflammation in healthy subjects","volume":"35","author":"Doyen","year":"2012","journal-title":"Inflammation"},{"key":"2020073006074856000_56.1.1901298.121","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2050-6511-15-60","article-title":"Anti-TNF inhibits the airways neutrophilic inflammation induced by inhaled endotoxin in human","volume":"15","author":"Michel","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"2020073006074856000_56.1.1901298.122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.07.039"},{"key":"2020073006074856000_56.1.1901298.123","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00228-015-1920-1","article-title":"Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects","volume":"71","author":"Singh","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"2020073006074856000_56.1.1901298.124","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.12.1047"},{"key":"2020073006074856000_56.1.1901298.125","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200503-451OC"},{"key":"2020073006074856000_56.1.1901298.126","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0933-6"},{"key":"2020073006074856000_56.1.1901298.127","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41467-019-09913-4","article-title":"Lipopolysaccharide inhalation recruits monocytes and dendritic cell subsets to the alveolar airspace","volume":"10","author":"Jardine","year":"2019","journal-title":"Nat Commun"},{"key":"2020073006074856000_56.1.1901298.128","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.02832.x"},{"key":"2020073006074856000_56.1.1901298.129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.09.002"},{"key":"2020073006074856000_56.1.1901298.130","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00113811"},{"key":"2020073006074856000_56.1.1901298.131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-9255-11-9","article-title":"Functional characterisation of human pulmonary monocyte-like cells in lipopolysaccharide-mediated acute lung inflammation","volume":"11","author":"Brittan","year":"2014","journal-title":"J Inflamm (Lond)"},{"key":"2020073006074856000_56.1.1901298.132","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201212-2334OC"},{"key":"2020073006074856000_56.1.1901298.133","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00170609"},{"key":"2020073006074856000_56.1.1901298.134","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00097.2006"},{"key":"2020073006074856000_56.1.1901298.135","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000262386.32287.29"},{"key":"2020073006074856000_56.1.1901298.136","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208597"},{"key":"2020073006074856000_56.1.1901298.137","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403285"},{"key":"2020073006074856000_56.1.1901298.138","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: Latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2020073006074856000_56.1.1901298.139","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201310-1892OC"},{"key":"2020073006074856000_56.1.1901298.140","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/bcp.13052","article-title":"Inflammation induced by inhaled lipopolysaccharide depends on particle size in healthy volunteers","volume":"82","author":"Doyen","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"2020073006074856000_56.1.1901298.141","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2008-0362OC"},{"key":"2020073006074856000_56.1.1901298.142"},{"key":"2020073006074856000_56.1.1901298.143","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.8.2.333-338.2001"},{"key":"2020073006074856000_56.1.1901298.144","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2346.2001.00958.x"},{"key":"2020073006074856000_56.1.1901298.145","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-097X.2011.01026.x"},{"key":"2020073006074856000_56.1.1901298.146","doi-asserted-by":"publisher","DOI":"10.1177\/1753425913481821"},{"key":"2020073006074856000_56.1.1901298.147","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03307.x"},{"key":"2020073006074856000_56.1.1901298.148","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000297875.55969.DB"},{"key":"2020073006074856000_56.1.1901298.149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087413"},{"key":"2020073006074856000_56.1.1901298.150","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000191383.34066.4b"},{"key":"2020073006074856000_56.1.1901298.151","doi-asserted-by":"publisher","DOI":"10.1016\/0954-6111(93)90074-A"},{"key":"2020073006074856000_56.1.1901298.152","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2466-13-19","article-title":"Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development","volume":"13","author":"Janssen","year":"2013","journal-title":"BMC Pulm Med"},{"key":"2020073006074856000_56.1.1901298.153","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jaci.2016.04.017","article-title":"Reproducibility of the inflammatory response to inhaled endotoxin in healthy volunteers","volume":"138","author":"Kobernick","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2020073006074856000_56.1.1901298.154","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000239768.64786.3a"},{"key":"2020073006074856000_56.1.1901298.155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2249.2008.03612.x","article-title":"Common studied polymorphisms do not affect plasma cytokine levels upon endotoxin exposure in humans","volume":"152","author":"Taudorf","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2020073006074856000_56.1.1901298.156","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.05.012"},{"key":"2020073006074856000_56.1.1901298.157","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.05.001"},{"key":"2020073006074856000_56.1.1901298.158","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-013-9758-0"},{"key":"2020073006074856000_56.1.1901298.159","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.069823"},{"key":"2020073006074856000_56.1.1901298.160","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2006.12.007"},{"key":"2020073006074856000_56.1.1901298.161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2014.01.032","article-title":"APO\u03b54 is associated with enhanced in vivo innate immune responses in human subjects","volume":"134","author":"Gale","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2020073006074856000_56.1.1901298.162","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3752"},{"key":"2020073006074856000_56.1.1901298.163","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00508-009-1182-y","article-title":"The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model","volume":"121","author":"Kovar","year":"2009","journal-title":"Wien Klin Wochenschr"},{"key":"2020073006074856000_56.1.1901298.164","doi-asserted-by":"publisher","DOI":"10.1136\/oem.2010.061747"},{"key":"2020073006074856000_56.1.1901298.165","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.1.79"},{"key":"2020073006074856000_56.1.1901298.166","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206488"},{"key":"2020073006074856000_56.1.1901298.167","doi-asserted-by":"publisher","DOI":"10.1177\/1753425909339923"},{"key":"2020073006074856000_56.1.1901298.168","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/CS20120194","article-title":"Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial","volume":"123","author":"Spiel","year":"2012","journal-title":"Clin Sci"},{"key":"2020073006074856000_56.1.1901298.169","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000030184.70207.FF"},{"key":"2020073006074856000_56.1.1901298.170","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201204-0645OC"},{"key":"2020073006074856000_56.1.1901298.171","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/CCM.0000000000003630","article-title":"Treatment With acetylsalicylic acid reverses endotoxin tolerance in humans in vivo: a randomized placebo-controlled study","volume":"47","author":"Leijte","year":"2019","journal-title":"Crit Care Med"},{"key":"2020073006074856000_56.1.1901298.172","doi-asserted-by":"publisher","DOI":"10.1038\/srep41926"},{"key":"2020073006074856000_56.1.1901298.173","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00380-06"},{"key":"2020073006074856000_56.1.1901298.174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059368"},{"key":"2020073006074856000_56.1.1901298.175","doi-asserted-by":"crossref","first-page":"R238","DOI":"10.1186\/cc13062","article-title":"Lipopolysaccharide infusion enhances dynamic cerebral autoregulation without affecting cerebral oxygen vasoreactivity in healthy volunteers","volume":"17","author":"Berg","year":"2013","journal-title":"Crit Care"},{"key":"2020073006074856000_56.1.1901298.176","doi-asserted-by":"crossref","first-page":"R1127","DOI":"10.1152\/ajpregu.00242.2012","article-title":"Disassociation of static and dynamic cerebral autoregulatory performance in healthy volunteers after lipopolysaccharide infusion and in patients with sepsis","volume":"303","author":"Berg","year":"2012","journal-title":"AJP Regul Integr Comp Physiol"},{"key":"2020073006074856000_56.1.1901298.177","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/bcp.13655","article-title":"Safety, tolerability and pharmacokinetics\/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects","volume":"84","author":"Geven","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"2020073006074856000_56.1.1901298.178","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1209793"},{"key":"2020073006074856000_56.1.1901298.179","doi-asserted-by":"publisher","DOI":"10.1038\/srep30162"},{"key":"2020073006074856000_56.1.1901298.180","doi-asserted-by":"publisher","DOI":"10.3109\/08958371003610966"},{"key":"2020073006074856000_56.1.1901298.181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.05.026"},{"key":"2020073006074856000_56.1.1901298.182","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.11.040"},{"key":"2020073006074856000_56.1.1901298.183","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2140"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01298-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:32:01Z","timestamp":1740382321000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01298-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":183,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,7,30]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1183\/13993003.01298-2019"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01298-2019","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}